Clinical Trials Browser

OTHER × Breast Neoplasms × elgemtumab × Clear all

NCT02167854 2021-07-09

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase 1 Completed

Breast Neoplasms